CA Stock MarketDetailed Quotes
HEM Hemostemix Inc
- 0.050
- 0.0000.00%
15min DelayTrading Jul 10 16:00 ET
4.36MMarket Cap-1666P/E (TTM)
0.000High0.000Low0Volume0.000Open0.050Pre Close0.00Turnover0.17552wk High0.00%Turnover Ratio87.12MShares0.03552wk Low-0.03EPS TTM3.72MFloat Cap25.000Historical HighLossP/E (Static)74.47MShs Float0.035Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM-0.59P/B1Lot Size--Div YieldTTM
About Hemostemix Inc Company
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.
Company Profile
SymbolHEM
Company NameHemostemix Inc
Founded2014
MarketTSX
Fiscal Year Ends12-31
Address707 - 7th Avenue SouthWest Suite 1150
CityCalgary
CountryCAN
Zip CodeT2P 3H6
Phone+1 905 580-4170
Websitehttps://www.hemostemix.com
Company Executives
- Name
- Position
- Salary
- Thomas Smeenk
- Director, President and Chief Executive Officer
- --
- Christina Wu
- Interim Chief Financial Officer
- --
- Dr. Fraser C. Henderson
- Chief Medical Officer
- --
- Peter Pavlin
- Vice President of Operations
- --
- Peter Alan Lacey
- Chairman of the Board
- --
- Loran Swanberg
- Independent Director
- --
- Dr. Ronnie Hershman
- Independent Director
- --
Heat List
CA
Overall
Symbol
Latest Price
%Chg